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INTRODUCTION
The purines constitute an important class of anti-inflammatory agents. Important members of this class include theophylline, theobromine and caffeine. They owe their anti-inflammatory action to their capacity to affect changes in the basic cellular functions. These compounds act as competitive inhibitors of phosphodiesterase, an enzyme which inactivates cyclic 3', 5'-adenosine monophosphate (3',5 '-c AMP) 1. The enzyme inhibition activates 3',5'-c AMP, which consequently stimulates glycoganolysis and promotes cellular processes. It has also been postulated that the purine drugs act by reducing the binding of calcium in the membrane and myoplasm of the cell, thereby affecting the contractility of the muscles1.
The interest in the metal complexes of purines has arisen for the following reasons: Firstly, as a result of antitumor activity of some metal complexes, considerable interest has been shown in the design of model complexes involving purines which could mimic the interaction of metal ions with DNA2-4. Secondly, a few metal-purine complexes have shown significant anti-inflammatory activity5.
Thirdly, the investigation of mercury-purine complexes is of particular value, since the known toxic effects of the organomercury compounds, which are attributed to the formation of mercury-sulphur bonds with sulphydryl functions in amino acids and proteins, may also be due, in part, to their interaction with nucleic acid constituents6. Therefore, we have carried out the synthesis of a few organomercury(ll)-purine complexes and have determined their structure and anti-inflammatory activity. 9 , the y (c=0) stretching frequency in free theophylline absorbed at 1680 and 1720 cm , while in the metal complexes it was shifted to 1630-1665 cm although the crystal structure data ruled out the involvement in complexation of the carbonyl group at C(6). In the present theophylline complex too, the band attributed to the y (c=0) stretching frequency was lowered from 1660 cm to 1630 cm. This shift, however, cannot be attributed to the interaction of the carbonyl at C(6) with mercury (11) ion, since the UV and 3C NMR data indicated the non-chelating behaviour of theophylline. In the case of theobromine and caffeine complexes, the y (c=0) stretching frequency remained unaltered on complexation. Substantial shift from ca. 1550 cm to ca. 1520 cm were observed for the purine ring modes10.
EXPERIMENTAL
UV Spectra. The UV spectra of theophylline, theobromine and caffeine showed an absorption band at 270 nm (log 7.5), 274 nm (log 6.2) and 272 nm (log 5.8), respectively due to the * transition of the chromophoric carbonyl group11. In the case of complexes, this absorption occurred at ca. 272 rim. Since no significant shift was observed in the Xmax value, the possibility of bonding through carbonyl group was ruled out.
H NMR Spectra. In the H NMR spectra, the theophyllinato group showed no significant shift on complexation. However in theobromine and caffeine, the signal due to H (8) , which absorbed at ca. 8 .00 (s, 1H), was shifted to 8.20 on complexation; the downfield shift was attributed to the involvement of N(9) in complexation.
C NMR Spectra. In the 3C NMR spectra, the signal at ca. 160 ppm in case of free ligands was attributed to the C(6) carbonyl. Since no significant shift was observed on complexation, it was concluded that the carbonyl at C(6) was not coordinated to the mercury (11) ion4. However, the resonance signal due to C (8) , which appeared at 140.1 ppm in theophylline, was shifted to 143 ppm in complex (I), supporting the assertion that complexation involved deprotonation at N(7). Similarly, in theobromine and caffeine the signal due to C(8) absorbed at ca. 134.5. In complexes (II-IV), this signal absorbed at ca. 138 ppm, supporting the involvement of N(9) in complexation.
Anti-Inflammatory Activity. The results of anti-inflammatory activity, presented in Table-l, reveal that at an oral dose of 100 mg kg , the test compounds, (I), (11) , (111) In the present study too, the variation in anti-inflammatory activity followed the above criteria. The complexes, (11) and (IV), which had both a chloro group and a nitro substituent in their structures, resulted in a significant inhibition of edema. Next in the anti-inflammatory action was the compound (111) which had a chloro group but no ionic substituent. The complex (I) which had neither a chloro group, nor an ionic substituent was least active of all the compounds considered in this investigation.
CONCLUSION
Although the concentration of test samples was different from that of indomethacin (reference drug), it was possible to make a comparative assessment of the anti-inflammatory activity o.f the compounds and also to study the variation of biological activity vis-a-vis the nature of substituents on the complexes.
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